Insufficient scRNA-seq data for expression of CTCFL at single-cell level.
Insufficient scRNA-seq data for expression of CTCFL at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 63% | 2.98 | 113 / 180 | 70% | 13.11 | 302 / 430 |
spleen | 97% | 14.43 | 233 / 241 | 0% | 0 | 0 / 0 |
liver | 82% | 10.96 | 185 / 226 | 0% | 0.01 | 2 / 406 |
thymus | 78% | 7.50 | 507 / 653 | 0% | 0.01 | 3 / 605 |
kidney | 76% | 12.09 | 68 / 89 | 0% | 0.01 | 2 / 901 |
uterus | 45% | 1.95 | 76 / 170 | 29% | 6.48 | 134 / 459 |
adipose | 73% | 5.95 | 878 / 1204 | 0% | 0 | 0 / 0 |
intestine | 60% | 3.31 | 583 / 966 | 2% | 0.25 | 8 / 527 |
stomach | 56% | 2.28 | 202 / 359 | 3% | 0.64 | 10 / 286 |
bladder | 57% | 2.00 | 12 / 21 | 2% | 0.27 | 12 / 504 |
lung | 50% | 2.35 | 287 / 578 | 9% | 1.93 | 105 / 1155 |
prostate | 58% | 4.44 | 143 / 245 | 0% | 0 | 0 / 502 |
breast | 57% | 3.29 | 262 / 459 | 1% | 0.03 | 6 / 1118 |
peripheral blood | 57% | 4.26 | 528 / 929 | 0% | 0 | 0 / 0 |
esophagus | 48% | 1.81 | 688 / 1445 | 8% | 2.04 | 14 / 183 |
brain | 55% | 3.17 | 1460 / 2642 | 0% | 0 | 0 / 705 |
skin | 38% | 1.65 | 680 / 1809 | 16% | 2.31 | 74 / 472 |
pancreas | 50% | 2.09 | 164 / 328 | 2% | 0.33 | 4 / 178 |
muscle | 44% | 2.57 | 357 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 38% | 1.34 | 505 / 1335 | 0% | 0 | 0 / 0 |
heart | 33% | 1.13 | 282 / 861 | 0% | 0 | 0 / 0 |
adrenal gland | 29% | 1.09 | 74 / 258 | 0% | 0.00 | 1 / 230 |
lymph node | 0% | 0 | 0 / 0 | 28% | 1.05 | 8 / 29 |
tonsil | 0% | 0 | 0 / 0 | 4% | 2.38 | 2 / 45 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0071169 | Biological process | establishment of protein localization to chromatin |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0071514 | Biological process | genomic imprinting |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0045815 | Biological process | transcription initiation-coupled chromatin remodeling |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005654 | Cellular component | nucleoplasm |
GO_0016604 | Cellular component | nuclear body |
GO_0005829 | Cellular component | cytosol |
GO_0005694 | Cellular component | chromosome |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0042393 | Molecular function | histone binding |
GO_0043565 | Molecular function | sequence-specific DNA binding |
GO_0000976 | Molecular function | transcription cis-regulatory region binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0043035 | Molecular function | chromatin insulator sequence binding |
GO_0005515 | Molecular function | protein binding |
Gene name | CTCFL |
Protein name | Transcriptional repressor CTCFL (Brother of the regulator of imprinted sites) (CCCTC-binding factor) (CTCF paralog) (CTCF-like protein) (Cancer/testis antigen 27) (CT27) (Zinc finger protein CTCF-T) CCCTC-binding factor like |
Synonyms | BORIS |
Description | FUNCTION: Testis-specific DNA binding protein responsible for insulator function, nuclear architecture and transcriptional control, which probably acts by recruiting epigenetic chromatin modifiers. Plays a key role in gene imprinting in male germline, by participating in the establishment of differential methylation at the IGF2/H19 imprinted control region (ICR). Directly binds the unmethylated H19 ICR and recruits the PRMT7 methyltransferase, leading to methylate histone H4 'Arg-3' to form H4R3sme2. This probably leads to recruit de novo DNA methyltransferases at these sites (By similarity). Seems to act as tumor suppressor. In association with DNMT1 and DNMT3B, involved in activation of BAG1 gene expression by binding to its promoter. Required for dimethylation of H3 lysine 4 (H3K4me2) of MYC and BRCA1 promoters. . |
Accessions | Q8NI51 V9GY73 ENST00000539382.5 [Q8NI51-5] V9GZ46 ENST00000481655.2 ENST00000423479.7 [Q8NI51-7] ENST00000608158.5 V9GYX4 ENST00000608425.5 F5H2V8 ENST00000608903.5 [Q8NI51-11] ENST00000422109.6 [Q8NI51-9] ENST00000371196.6 [Q8NI51-1] ENST00000432255.6 [Q8NI51-4] ENST00000243914.8 [Q8NI51-1] ENST00000608440.5 [Q8NI51-3] ENST00000422869.6 [Q8NI51-2] ENST00000609232.5 [Q8NI51-1] ENST00000608263.5 [Q8NI51-1] ENST00000433949.7 [Q8NI51-10] ENST00000426658.6 ENST00000429804.7 [Q8NI51-8] ENST00000502686.6 [Q8NI51-6] ENST00000608720.5 |